Applied Thermal Engineering
Издатель: Elsevier · ISSN 1359-4311 · 18 статей
-
Editorial Board
Publication date: September 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 94 Author(s):
-
The preclinical discovery and development of depemokimab for severe eosinophilic asthma
Publication date: September 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 94 Author(s): Mario Cazzola, Vincenzo Patella, Raffaella Pagliaro, Andrea Bianco, Paola Rogliani, Maria Gabriella Matera
-
Brain-derived neurotrophic factor (BDNF) signaling in respiratory disease: Mechanisms, neuroimmune crosstalk, and therapeutic implications
Publication date: September 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 94 Author(s): Entesar Yaseen Abdo Qaid, Idris Long
-
PD05, a novel neutrophil elastase inhibitor, mitigates LPS-induced acute lung injury in a preclinical model
Publication date: September 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 94 Author(s): Sabita Singh, Ashish Jaiswal, Joytri Dutta, Archita Ray, Sayantan Sengupta, Sudip Dey, Arun Bandyopadhyay, Parasuraman Jaisankar,...
-
Effects of anumigilimab, an anti–G-CSF receptor mAb, after segmental LPS challenge: A Phase 1b trial in healthy volunteers
Publication date: September 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 94 Author(s): Jens M. Hohlfeld, Meike Müller, Philipp Badorrek, Laurent B. Nicolas, Oliver Vit, William G. Darby, Judith Field, Michael Larbig
-
Real-life application of the optical beta-adrenergic sweat test for people with cystic fibrosis
Publication date: September 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 94 Author(s): Karina Kleinfelder, Anca Manuela Hristodor, Giorgio Centin, Antonella Casiraghi, Paola Minghetti, Emily Pintani, Marina Bertini,...
-
m 6 A reader IGF2BP2 mediates airway remodeling by stabilizing Dixdc1 in asthma pathogenesis
Publication date: September 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 94 Author(s): Xiao-Mang Li, Bi-Wen Mo, Yan Gao, Yun-Xiang Chen, Bo Xiao, Yue Gu, Miao-Miao Liang, Hui-Min Li
-
TROP2 as a promising therapeutic target in lung cancer: Current clinical trial landscape and future directions
Publication date: September 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 94 Author(s): Maosen Liu, Ruihang Luo, Yichen Liu, Yuxin Fan, Jingtao Zhang, Mingshan Liu
-
Methodological considerations on the effectiveness of biologics in asthma-COPD overlap
Publication date: September 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 94 Author(s): Tingfang Liu, Ye Jian
-
Steroid-sparing strategies in respiratory diseases: efficacy and safety of current therapeutic options
Publication date: December 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 95 Author(s): Mateusz Gadzała, Aleksandra Paź, Dagmara Mirowska-Guzel
-
Targeting pulmonary and arterial chemoreceptors via inhaled therapeutics: A novel pathway to blunt hypoxia-induced pulmonary hypertension?
Publication date: December 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 95 Author(s): Durlav Chowdhury, Surendra H. Bodakhe
-
Cellular senescence and vascular ageing in pulmonary hypertension: Molecular mechanisms, therapeutic strategies, and translational endpoints
Publication date: December 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 95 Author(s): Yide Chen, Xiaolan Wang, Meng Gao, Qinei Zheng, Qianyue Zhang, Ting Liu, Shuanglan Xu, Jiao Yang, Xiqian Xing
-
Efficacy and safety of magnesium glycinate as add on therapy in hypomagnesemic asthma and chronic obstructive pulmonary disease patients: A randomised controlled study assessing inflammatory biomarkers
Publication date: December 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 95 Author(s): Maneesh Kumar Maddirevula, Muhasaparur G. Rajanandh, Boman Wesley
-
TNF-α–mediated molecular switching links COPD to lung cancer: Integrated in silico and in vivo study of oxidative stress–driven disease transition
Publication date: December 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 95 Author(s): Riya Manna, Jagannath Das, Debraj Roy, Sampurna Bhattacharya, Sudipto Saha, Runa Sur, I.B. Chatterjee, Rajat Banerjee
-
Belumosudil improves experimental pulmonary fibrosis via the ROCK2/Smad3/CTGF pathway
Publication date: December 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 95 Author(s): Dexin Kong, Guanghua Zhang, Zhonghong Jiang, Wanglin Jiang
-
Pharmacological enhancement of O-GlcNAcylation attenuates lung ischemia-reperfusion injury
Publication date: December 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 95 Author(s): Yang Jin, Yu Fu, Nan Zhang, Xuemei Jiang, Jiameng Gao, Zhiyuan Zhang, Xiaotong Huang, Maojun Zhou, Chang Chen, Zongmei Wen
-
Tectochrysin alleviates idiopathic pulmonary fibrosis via inhibiting PI3K/AKT/mTOR signaling pathway by targeting PI3K p85
Publication date: December 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 95 Author(s): Mengying Li, Tingfang Xiao, Xuanyu Chen, Zhihe Liu, Haoyu Ji, Huiwen Chen, Xinru Xi, Yali Zhang, Xiaona Zhu
-
First-in-human safety and pharmacokinetic evaluation of seralutinib, an investigational inhaled tyrosine-protein kinase inhibitor for pulmonary hypertension
Publication date: December 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 95 Author(s): Jianke Li, Lawrence S. Zisman, Matt Cravets, Richard Aranda